Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams
To access this article, please choose from the options below
PII: S0090-4295(09)03070-2
doi:10.1016/j.urology.2009.12.010
© 2010 Elsevier Inc. All rights reserved.
